• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) JUVEDERM ULTRA PLUS XC 0,8ML (1 ML COC); IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) JUVEDERM ULTRA PLUS XC 0,8ML (1 ML COC); IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 94155ED
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Peeling (1999); Vascular System (Circulation), Impaired (2572)
Event Date 09/11/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.This is a known potential adverse event addressed in the product labeling.
 
Event Description
Healthcare professional reported to have had injected a patient in the lips with 1 ml of juvéderm ultra plus¿ xc.Numbing cream was used as pre-treatment.On the following day, the patient called the injector to report ¿bruising outside of lip area and that lips were painful.¿ there was vascular occlusion in the lip and chin.The patient attended to the facility for a review and the doctor advised to hylase®.Hylase® was used on the same day, the day after, and once more the day after that.The patient is "still a little red on [the] chin where [the patient] scabbed but that has healed".The patient was seen for a review about 2 weeks later and "it had resolved".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JUVEDERM ULTRA PLUS XC 0,8ML (1 ML COC)
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR  74370
Manufacturer (Section G)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR   74370
Manufacturer Contact
michelle burgess
301 w howard lane
suite 100
austin, TX 78753
7372473605
MDR Report Key9179329
MDR Text Key173190739
Report Number3005113652-2019-00703
Device Sequence Number1
Product Code LMH
Combination Product (y/n)Y
Reporter Country CodeAS
PMA/PMN Number
P050047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Nurse
Type of Report Initial
Report Date 10/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/11/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/31/2020
Device Catalogue Number94155ED
Device Lot NumberH30LA80619
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/13/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age19 YR
-
-